Brief: Spago Nanomedical Q4 Loss Widens To SEK 11.3 Mln
Feb 2 (Reuters) - Spago Nanomedical:
* Q4 NET SALES FOR QUARTER AMOUNTED TO KSEK 99 (KSEK 175)
* Q4 LOSS FOR QUARTER AMOUNTED TO KSEK -11,293 (KSEK -4,624)
* Q4 OPERATING EXPENSES FOR QUARTER AMOUNTED TO KSEK -13,078
(KSEK
-7,161)
Source text for Eikon: ID:nMFN4XShf6
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose